Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Neuronostics logo — Revolutionising diagnosis and prognosis of neurological cond...

Neuronostics

Revolutionising diagnosis and prognosis of neurological conditions

Founded 2018 United Kingdom Bristol, United Kingdom 16 employees Seed Total: $4.51M Medical Devices

General Information

Company Name Neuronostics
Founded Year 2018
Location United Kingdom Bristol, United Kingdom +2
Employees 16
Industries Medical Devices
Funding Stage Seed
Social

Get notified when Neuronostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Neuronostics

Neuronostics, founded in 2018 and headquartered in the United Kingdom, is revolutionizing the diagnosis and prognosis of neurological conditions. The company's slogan, "Revolutionising diagnosis and prognosis of neurological conditions," encapsulates their mission. Neuronostics utilizes mathematical modeling to develop novel biomarkers, creating faster paths to diagnosis and effective treatment. With BioEP as their first clinical indication, they have introduced a digital biomarker for epilepsy, which utilizes background EEG data and mathematical modeling to predict the likelihood of seizures. This innovation supports clinical diagnostic and prognostic decisions for epilepsy. The recent £2.10M Seed Round investment on 05 April 2024, with contributions from QantX, Cornwall & Isles of Scilly Investment Fund, Empirical Ventures, and Ascension Life Fund, signifies confidence in Neuronostics' potential to transform neurological healthcare and improve the lives of individuals at risk of or living with neurological conditions. The company's vision of integrating digital biomarkers into neurology centers worldwide is poised to create a proactive and anticipatory model of care, ultimately revolutionizing neurological healthcare.

Taxonomy: Neuroscience, Diagnostic tools, Prognostic tools, Pharmaceutical, EEG, Hardware, Partnership, Technology integration, Medical devices, Research and development, Neurological disorders

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 4
Investor Investor
•••• •••• 		05 Apr 2024
Seed Round •••••• 1
Investor
04 Oct 2023
Seed Round •••••• 1
Investor
26 Mar 2021
Grant •••••• 1 •••• •••• 08 Sep 2020
Grant •••••• 1
Investor
01 Jun 2020

View All 7 Funding Rounds

Neuronostics Alternatives & Competitors

Neuronostics vs
Cavion
Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inhibition

Series A
Biotechnology, Health Care
Neuronostics vs
CenSyn, Inc.
CenSyn, Inc. United States

Instant insight, one mind at a time.

Grant
6 employees
Health Care, Medical Devices
Neuronostics vs
APRINOIA Therapeutics
APRINOIA Therapeutics

Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that...

Series Unknown
24 employees
Biotechnology, Health Care

FAQ About Neuronostics

Revolutionising diagnosis and prognosis of neurological conditions
Neuronostics was founded in 2018.
Neuronostics is headquartered in Bristol, United Kingdom.
Neuronostics operates in the following industries: Medical Devices.
Neuronostics has approximately 16 employees.
Neuronostics has completed 7 funding rounds, raising a total of $4.51M. The latest funding stage is Seed.
Top alternatives and competitors to Neuronostics include Cavion, CenSyn, Inc., APRINOIA Therapeutics, Revalesio, Xenon Pharmaceuticals Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neuronostics and Cavion are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Neuronostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy